A Modular Platform for Magnetically Guided Injectable Particles

Abstract: Magnetically guided injectable particles offer a minimally invasive alternative to catheter‑based interventions for delivering therapy to deep or anatomically complex regions such as the brain, spine, and major joints. By injecting particles into upstream vessels and allowing natural blood flow to transport them toward the target, external magnetic fields can bias their movement, increase local concentration, and retain them within the microvasculature. Combined with molecular targeting ligands and disease‑specific payloads, this platform enables precise treatment of tumours, blood clots, inflammation, infection, and other pathological conditions without the need for hardware navigation. Activation through near‑infrared light, alternating magnetic fields, or chemical triggers confines therapeutic action to the target site, reducing systemic exposure. This modular approach integrates established knowledge from nanomedicine, interventional radiology, and magnetic field control into a unified delivery system capable of reaching regions previously inaccessible to conventional tools, with the potential to improve safety, precision, and patient quality of life.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-19
DOI
https://doi.org/10.5281/zenodo.22838210
Primary Topic
Nanoparticle-Based Drug Delivery
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
preprint

A Modular Platform for Magnetically Guided Injectable Particles

MICHAEL BISWELL
Zenodo (CERN European Organization for Nuclear Research)
Nanoparticle-Based Drug Delivery
preprint

A Modular Platform for Magnetically Guided Injectable Particles

MICHAEL BISWELL
preprint en

Abstract

Abstract: Magnetically guided injectable particles offer a minimally invasive alternative to catheter‑based interventions for delivering therapy to deep or anatomically complex regions such as the brain, spine, and major joints. By injecting particles into upstream vessels and allowing natural blood flow to transport them toward the target, external magnetic fields can bias their movement, increase local concentration, and retain them within the microvasculature. Combined with molecular targeting ligands and disease‑specific payloads, this platform enables precise treatment of tumours, blood clots, inflammation, infection, and other pathological conditions without the need for hardware navigation. Activation through near‑infrared light, alternating magnetic fields, or chemical triggers confines therapeutic action to the target site, reducing systemic exposure. This modular approach integrates established knowledge from nanomedicine, interventional radiology, and magnetic field control into a unified delivery system capable of reaching regions previously inaccessible to conventional tools, with the potential to improve safety, precision, and patient quality of life.

Zenodo (CERN European Organization for Nuclear Research)
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Modular Platform for Magnetically Guided Injectable Particles — MICHAEL BISWELL · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS